We summarize demographics and baseline clinical characteristics using descriptive statistics; continuous data are summarized with number of mean or geometric mean (where noted) and standard deviation (SD). Categorical data are summarized using proportions.

We defined baseline eGFR for the study as the average of the 2 screening measurements and the day 1 eGFR measurement. For evaluation of the eGFR trajectory before trial participation, we obtained all eGFR values before trial participation going as far back as the eGFR value closest to 5 years but not >5.5 years and calculated the annualized eGFR slope (in mL/min/1.73 m2/year). We employed a longitudinal mixed model with the eGFR at each available time point as the dependent variable and time in years as the covariate. UACR results were log transformed for analysis and summarized using geometric means. In accordance with published guidance, we did not perform inference tests comparing baseline characteristics across groups.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.